Governments must 'act now' to meet target to cut cancer deaths

1 November 2016

“With just under 10 years left to meet the target of reducing premature deaths from non-communicable (NCDs) diseases by 25%, governments and policy-makers must act now to ensure equitable access to services to allow people to live with and survive cancer.”

Those were the words of Tezer Kutluk, president of the Union for International Cancer Control (UICC), at the World Cancer Leaders’ Summit (WCLS) which is taking place in Paris this week.

Around 250 health leaders and cancer experts from around the world have gathered at the event to discuss and influence global strategy for cancer control.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK